Dr. Spurgeon completed his undergraduate work at Bowdoin College and his medical school at Thomas Jefferson University. This was followed by his internal medicine residency, chief residency, and fellowship training at Oregon Health & Science University (OHSU) after which he joined the faculty in 2009. Throughout his career, he has focused on the care of patients with lymphoma and Chronic Lymphocytic Leukemia. He is an expert in clinical and translational research with a focus on novel therapeutics and clinical trials.

He has held a number of leadership positions within the division of hematology and medical oncology and the Knight Cancer Institute (KCI) at OHSU including co-chair of the Clinical Research Review Committee (CRRC), chief of hematologic malignancies section, and as the Lymphoma and CLL Program Director. He currently is active within the SWOG lymphoma committee and Lymphoma Research Foundation's Mantle Cell Lymphoma sub-committe. In 2020 was named the Distinguished Scholar of Leukemia and Lymphoma Research, and endowed post at the KCI.

In his free time, Dr. Spurgeon enjoys spending time with his family, the outdoors/skiing, exploring restaurants, and is a rabid University of Utah sports fan/homer.